Hazel Therapeutics ApS
CVR 46294238 · Private limited company (ApS) · Active · High risk
Hazel Therapeutics ApS is a Private limited company (ApS), founded on , based in København SV. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 4.5% over the next 12 months, which is 3.2 times the average for Danish companies.
Bankruptcy risk for Hazel Therapeutics ApS
3.2 × the average (1.41%) · higher risk than 91% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46294238
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- c/o Ditte Elisabeth Jæhger, Martin Luther Kings Vej 23, st. tv
2450 København SV - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Lorentzen & Partners, Statsautoriserede Revisorer ApS
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Owner (15%) | TLA-HOLDING 2010 ApS | Current | |
| Owner (10%) | Bastholm-Hansen Holding ApS | Current | |
| Owner (10%) | JHSCI Holding ApS | Current | |
| Owner (33%) | Verdande Holding ApS | Current | |
| Owner (10%) | Mitalone Holding ApS | Current | |
| Owner (5%) | Tobias Winkler | Current | |
| Auditor | Lorentzen & Partners, Statsautoriserede Revisorer ApS | Current | |
| Founder | TLA-HOLDING 2010 ApS | Current | |
| Founder | Bastholm-Hansen Holding ApS | Current | |
| Founder | JHSCI Holding ApS | Current | |
| Founder | Verdande Holding ApS | Current | |
| Founder | Mitalone Holding ApS | Current | |
| Founder | Tobias Winkler | Current |
Address history (0 moves)
| c/o Ditte Elisabeth Jæhger, Martin Luther Kings Vej 23, st. tv, 2450 København SV |
Other companies at the same address
- RULEBREAKER HOLDING ApS Active
- Rentablo ApS Active
- Rosford Vin Import ApS Opløst
- Verdande Holding ApS Active
- Zentablo ApS Fusioneret
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about Hazel Therapeutics ApS
Has Hazel Therapeutics ApS gone bankrupt?
No, Hazel Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Hazel Therapeutics ApS?
Our model estimates a bankruptcy risk of 4.5% over the next 12 months (high risk), which is 3.2 times the average for Danish companies.
Who is the auditor of Hazel Therapeutics ApS?
Hazel Therapeutics ApS most recently used Lorentzen & Partners, Statsautoriserede Revisorer ApS.
When was Hazel Therapeutics ApS founded?
Hazel Therapeutics ApS was founded on 19 February 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.